These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33657264)

  • 21. Omalizumab discontinuation in children with severe allergic asthma: An observational real-life study.
    Deschildre A; Roussel J; Drumez E; Abou-Taam R; Rames C; Le Roux P; Pouessel G; Scalbert M; Bonnel C; Mitha S; Boileau S; Mordacq C; Thumerelle C; Labreuche J; Lejeune S; Marguet C
    Allergy; 2019 May; 74(5):999-1003. PubMed ID: 30481388
    [No Abstract]   [Full Text] [Related]  

  • 22. Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down?
    Abrams EM; Szefler S
    Lancet Respir Med; 2021 Aug; 9(8):820-822. PubMed ID: 34252377
    [No Abstract]   [Full Text] [Related]  

  • 23. Effectiveness of Omalizumab in Severe Allergic Asthma and Nasal Polyposis: A Real-Life Study.
    Tiotiu A; Oster JP; Roux PR; Nguyen Thi PL; Peiffer G; Bonniaud P; Dalphin JC; de Blay F
    J Investig Allergol Clin Immunol; 2020; 30(1):49-57. PubMed ID: 30931917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance.
    Nakamura N; Kashitani Y; Yoshisue H; Nagasaki M; Sasajima T
    Allergol Int; 2021 Jul; 70(3):319-326. PubMed ID: 33526351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ongoing impact of Covid-19 pandemic on children with medical complexity: the experience of an Italian pediatric palliative care network.
    Grigoletto V; Nardin B; Taucar V; Barbi E; De Zen L
    Ital J Pediatr; 2022 Jan; 48(1):10. PubMed ID: 35042551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review.
    Colombo GL; Di Matteo S; Martinotti C; Oselin M; Valentino MC; Bruno GM; Pitotti C; Menzella F
    Ther Adv Respir Dis; 2019; 13():1753466619841350. PubMed ID: 31035904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and safety of omalizumab in severe, persistent IgE-mediated asthma in pediatric and adult patients: a real-world observational study in Egyptian population.
    Tarraf HN; Masoud HH; Zidan M; Wahba B
    J Asthma; 2020 Feb; 57(2):160-166. PubMed ID: 30592242
    [No Abstract]   [Full Text] [Related]  

  • 28. COVID-19 in patients with severe asthma using biological agents.
    Aksu K; Demir Ş; Topel M; Yeşilkaya S; Ateş H; Koca Kalkan İ; Öncül A; Çuhadar Erçelebi D; Türkyılmaz S
    Tuberk Toraks; 2021 Sep; 69(3):433-436. PubMed ID: 34581170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the clinical features and laboratory data of patients with severe asthma classified as super-responder or non super-responder to omalizumab treatment: a single-center real-life study.
    Cakmak ME; Öztop N; Yeğit OO; Özdedeoğlu Ö
    J Asthma; 2023 Oct; 60(10):1862-1868. PubMed ID: 36971065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of omalizumab in children and adolescents with moderate-to-severe asthma: A systematic literature review.
    Corren J; Kavati A; Ortiz B; Colby JA; Ruiz K; Maiese BA; Cadarette SM; Panettieri RA
    Allergy Asthma Proc; 2017 Jul; 38(4):250-263. PubMed ID: 28631599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asthma and allergic diseases are not risk factors for hospitalization in children with coronavirus disease 2019.
    Beken B; Ozturk GK; Aygun FD; Aydogmus C; Akar HH
    Ann Allergy Asthma Immunol; 2021 May; 126(5):569-575. PubMed ID: 33493639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-time effects of COVID-19 pandemic lockdown on pediatric respiratory patients.
    Cahal M; Amirav I; Diamant N; Be'er M; Besor O; Lavie M
    Pediatr Pulmonol; 2021 Jun; 56(6):1401-1408. PubMed ID: 33729709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement in quality of life with omalizumab in patients with severe allergic asthma.
    Chipps B; Buhl R; Beeh KM; Fox H; Thomas K; Reisner C
    Curr Med Res Opin; 2006 Nov; 22(11):2201-8. PubMed ID: 17076981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric severe asthma: a case series report and perspectives on anti-IgE treatment.
    Mirra V; Montella S; Santamaria F
    BMC Pediatr; 2018 Feb; 18(1):73. PubMed ID: 29466963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and effectiveness of omalizumab in the treatment of childhood asthma.
    Tortajada-Girbés M; Bousquet R; Bosque M; Carrera Martínez JJ; Ibáñez MD; Moreira A; Nieto A; Plaza AM; Rivas C; Requena G; Sánchez-Solis M; Tabar A; Torres-Borrego J; Zapatero L
    Expert Rev Respir Med; 2018 Sep; 12(9):745-754. PubMed ID: 30141696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study.
    Pelaia C; Calabrese C; Barbuto S; Busceti MT; Preianò M; Gallelli L; Savino R; Vatrella A; Pelaia G
    Pulm Pharmacol Ther; 2019 Feb; 54():25-30. PubMed ID: 30414440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effectiveness of target therapy in patients with severe allergic asthma].
    Skorokhodkina OV; Valeeva AR; Luntsov AV; Pozdnyak VA
    Ter Arkh; 2019 Dec; 91(12):57-62. PubMed ID: 32598590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-life survey on severe asthma patients during COVID-19 lockdown in Italy.
    Caruso C; Colantuono S; Urbani S; Heffler E; Canonica GW; Andriollo G; Di Michele L; Scarlata S; Zennaro D; Rigon A; Vadacca M; Moroni R; Nucera E; Gasbarrini A
    Expert Rev Respir Med; 2021 Aug; 15(8):1057-1060. PubMed ID: 33896350
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in asthma control, work productivity, and impairment with omalizumab: 5-year EXCELS study results.
    Zazzali JL; Raimundo KP; Trzaskoma B; Rosén KE; Schatz M
    Allergy Asthma Proc; 2015; 36(4):283-92. PubMed ID: 26108086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A telehealth intervention for ensuring continuity of care of pediatric obesity during the CoVid-19 lockdown in Italy.
    Pecoraro P; Gallè F; Muscariello E; Di Mauro V; Daniele O; Forte S; Ricchiuti R; Liguori G; Valerio G
    Nutr Metab Cardiovasc Dis; 2021 Nov; 31(12):3502-3507. PubMed ID: 34728130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.